On 31 January 2019, the applicant also made a request to the Commission for the protection of proprietary data for a number of studies submitted in support of the application, namely, the proprietary analytical reports on the structure comparison via nuclear magnetic resonance (‘NMR’) of 6’-SL produced by bacterial fermentation with 6’-SL naturally present in human milk [Glykos Finland LTD 2018 (unpublished).]; the detailed characterisation data on the production bacterial strains [Glycom 2019 (unpublished).] and their certificates [Glycom/DSMZ 2018 (unpublished).]; the specifications for the raw materials and processing aids [Glycom 2019 (unpublished).]; the certificates of analyses of the various 6’-SL sodium salt batches [Glycom 2019 (unpublished).]; the analytical methods and validation reports [Glycom 2019 (unpublished).]; the 6’-SL sodium salt stability reports [Glycom 2019 (unpublished).]; the detailed description of the production process [Glycom 2018 (unpublished).]; the laboratory accreditation certificates [Glycom 2019 (unpublished).]; the 6’-SL intake assessment reports [Glycom 2019 (unpublished).]; an in vitro mammalian cell micronucleus test with 6’-SL sodium salt [Gilby 2018 (unpublished).]; an in vitro mammalian cell micronucleus test with the related compound 3’-sialyllactose (‘3’-SL’) sodium salt [Gilby 2019 (unpublished).]; a bacterial reverse mutation test with 6’-SL sodium salt [Šoltésová, 2018a (unpublished).]; a bacterial reverse mutation test with 3’-SL sodium salt [Šoltésová, 2018b (unpublished).]; a 14-day oral toxicity study in the neonatal rat with 6’-SL sodium salt [Flaxmer 2018a (unpublished).]; a 90-day oral toxicity study in the neonatal rat with 6’-SL sodium salt, including the summary table of the statistically significant observations [Flaxmer 2018b (unpublished).]; a 14-day oral toxicity study in the neonatal rat with 3’-SL sodium salt [Stannard 2019a (unpublished).]; and a 90-day oral toxicity study in the neonatal rat with 3’-SL sodium salt, including the summary table of the statistically significant observations [Stannard 2019b (unpublished).].
Recital 4, Regulation (EU) 2021/82
In forcesince 27 Jan 2021